Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

Van Andel Institute scientists and collaborators have developed a new method for identifying and classifying pancreatic ...

Results of a study show convergent genetic adaptation under hypoxia (lack of oxygen) between populations living at ...

"Ovarian cancer can be devastating and, when cancer cells stop responding to chemotherapy, patients may feel hopeless about their journey," said Svetlana Kobina, AbbVie's head of oncology medical ...

2025 — Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

Stem cells are cells that have the capacity to self-renew by dividing and to develop into more mature, specialised cells. Stem cells can be unipotent, multipotent, pluripotent or totipotent ...

Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...